Capital Research Global Investors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.63B Buy
17,112,218
+10,850,420
+173% +$3.23B 0.72% 32
2025
Q4
$2.07B Sell
6,261,798
-6,780,251
-52% -$2.3B 0.38% 57
2025
Q3
$4.5B Buy
13,042,049
+7,293,009
+127% +$2.21B 0.85% 24
2025
Q2
$1.79B Sell
5,749,040
-15,078,082
-72% -$5.76B 0.36% 66
2025
Q1
$10.9B Buy
20,827,122
+2,860,632
+16% +$1.46B 2.37% 6
2024
Q4
$9.09B Sell
17,966,490
-15,806
-0.1% -$8.98M 1.87% 7
2024
Q3
$10.5B Buy
17,982,296
+413,274
+2% +$234M 2.19% 6
2024
Q2
$8.95B Buy
17,569,022
+4,414,540
+34% +$2.16B 1.96% 10
2024
Q1
$6.51B Sell
13,154,482
-1,967,721
-13% -$1B 1.47% 10
2023
Q4
$7.96B Buy
15,122,203
+324,733
+2% +$173M 1.96% 7
2023
Q3
$7.46B Buy
14,797,470
+393,455
+3% +$194M 2.05% 7
2023
Q2
$6.92B Sell
14,404,015
-471,482
-3% -$231M 1.86% 7
2023
Q1
$7.03B Sell
14,875,497
-2,430,025
-14% -$1.17B 2.01% 7
2022
Q4
$9.18B Sell
17,305,522
-1,390,939
-7% -$737M 2.77% 3
2022
Q3
$9.44B Sell
18,696,461
-526,956
-3% -$277M 3.1% 3
2022
Q2
$9.87B Sell
19,223,417
-50,274
-0.3% -$25.2M 3.08% 3
2022
Q1
$9.83B Buy
19,273,691
+1,482,338
+8% +$715M 2.43% 4
2021
Q4
$8.93B Sell
17,791,353
-234,019
-1% -$106M 1.97% 8
2021
Q3
$7.04B Sell
18,025,372
-110,107
-0.6% -$45.6M 1.64% 11
2021
Q2
$7.26B Sell
18,135,479
-915,290
-5% -$365M 1.69% 11
2021
Q1
$7.09B Sell
19,050,769
-2,906,998
-13% -$1.01B 1.73% 11
2020
Q4
$7.7B Sell
21,957,767
-234,886
-1% -$78.7M 2% 7
2020
Q3
$6.92B Sell
22,192,653
-718,755
-3% -$221M 2.08% 9
2020
Q2
$6.76B Buy
22,911,408
+132,599
+0.6% +$38M 2.14% 9
2020
Q1
$5.68B Sell
22,778,809
-7,072,207
-24% -$1.95B 2.23% 9
2019
Q4
$8.78B Buy
29,851,016
+7,261,158
+32% +$1.9B 2.63% 5
2019
Q3
$4.91B Buy
22,589,858
+496,961
+2% +$120M 1.61% 9
2019
Q2
$5.39B Buy
22,092,897
+4,229,363
+24% +$1.02B 1.71% 10
2019
Q1
$4.42B Sell
17,863,534
-1,370,317
-7% -$349M 1.4% 17
2018
Q4
$4.79B Buy
19,233,851
+181,197
+1% +$47.9M 1.67% 12
2018
Q3
$5.07B Sell
19,052,654
-5,456,594
-22% -$1.42B 1.47% 15
2018
Q2
$6.01B Buy
24,509,248
+1,998,446
+9% +$480M 1.64% 11
2018
Q1
$4.82B Buy
22,510,802
+2,322,687
+12% +$531M 1.37% 12
2017
Q4
$4.45B Sell
20,188,115
-306,395
-1% -$64.9M 1.31% 17
2017
Q3
$4.01B Sell
20,494,510
-1,329,297
-6% -$257M 1.21% 19
2017
Q2
$4.05B Sell
21,823,807
-1,315,442
-6% -$231M 1.27% 18
2017
Q1
$3.8B Sell
23,139,249
-2,384,348
-9% -$390M 1.2% 16
2016
Q4
$4.08B Sell
25,523,597
-3,593,785
-12% -$537M 1.32% 15
2016
Q3
$4.08B Sell
29,117,382
-1,206
-0% -$169K 1.35% 16
2016
Q2
$4.11B Buy
29,118,588
+147,410
+0.5% +$19.7M 1.41% 12
2016
Q1
$3.73B Buy
28,971,178
+1,013,065
+4% +$120M 1.29% 13
2015
Q4
$3.29B Buy
27,958,113
+456,650
+2% +$53.4M 1.13% 19
2015
Q3
$3.19B Buy
27,501,463
+921,000
+3% +$110M 1.14% 19
2015
Q2
$3.24B Sell
26,580,463
-675,486
-2% -$79.9M 1.07% 17
2015
Q1
$3.22B Sell
27,255,949
-1,474,887
-5% -$164M 1.1% 16
2014
Q4
$2.9B Buy
28,730,836
+16,046
+0.1% +$1.52M 0.99% 19
2014
Q3
$2.48B Buy
28,714,790
+226,000
+0.8% +$19.1M 0.86% 24
2014
Q2
$2.33B Buy
28,488,790
+1,380,400
+5% +$109M 0.81% 28
2014
Q1
$2.22B Sell
27,108,390
-10,195,233
-27% -$767M 0.8% 29
2013
Q4
$2.81B Buy
37,303,623
+2,291,300
+7% +$165M 1.04% 17
2013
Q3
$2.51B Buy
35,012,323
+791,136
+2% +$56.6M 0.99% 20
2013
Q2
$2.24B Buy
+34,221,187
New +$2.13B 0.95% 23

Other funds holding UNH

Capital Research Global Investors's UNH Position: Q1 2026 in Review

Capital Research Global Investors increased its UnitedHealth (UNH) stake by 173% in Q1 2026, buying an estimated $3.23B and bringing the position to 17,112,218 shares worth $4.63B. The position accounts for 0.72% of the portfolio, ranked #32.

Capital Research Global Investors first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.9B in Q1 2025. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Capital Research Global Investors held 17,112,218 shares of UnitedHealth worth $4.63B as of Q1 2026.
  • Capital Research Global Investors bought 10,850,420 UnitedHealth shares in Q1 2026, an estimated $3.23B.
  • UnitedHealth made up 0.72% of Capital Research Global Investors's portfolio in Q1 2026, its #32 holding.
  • Capital Research Global Investors first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • Capital Research Global Investors's UnitedHealth position peaked at $10.9B in Q1 2025.
  • 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.